<DOC>
	<DOCNO>NCT01923844</DOCNO>
	<brief_summary>Exogenous bolus surfactant administration may affect hemodynamic parameter peripheral perfusion . Surfactant therapy commonly use respiratory distress syndrome premature infant , also associate inflammation . There different type dose surfactant preparation available . With help new generation monitor , change peripheral perfusion transcutaneous CO , marker inflammation , may demonstrate .</brief_summary>
	<brief_title>Effects Bolus Surfactant Therapy Peripheral Perfusion Index Tissue Carbon Monoxide</brief_title>
	<detailed_description>Preterm infant severe Respiratory Distress Syndrome ( study group ) compare preterm infant without Respiratory Distress Syndrome ( control group ) . Infants study group randomize receive either poractantalfa beractant . Perfusion index ( PI ) transcutaneous CO ( TCO ) value measure ( Tp ) 0 ( T0 ) , 5 ( T5 ) , 30 ( T30 ) , 60 ( T60 ) , 360 ( T360 ) minute surfactant administration first six hour life .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Carbon Monoxide</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Beractant</mesh_term>
	<criteria>Gestational age 26 36 week intubated respiratory distress syndrome cardiac defect , hemodynamically significant patent ductusarteriosus , congenital pneumonia , early sepsis unstable infant need inotropic support .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Day</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Newborn</keyword>
	<keyword>perfusion index</keyword>
	<keyword>pulsatility index</keyword>
	<keyword>respiratory distress syndrome</keyword>
	<keyword>surfactant</keyword>
	<keyword>transcutaneous carbon monoxide</keyword>
</DOC>